These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1854656)

  • 1. Effect of a bradycardic agent on the isolated blood-perfused canine heart.
    Schipke JD; Harasawa Y; Sugiura S; Alexander J; Burkhoff D
    Cardiovasc Drugs Ther; 1991 Apr; 5(2):481-8. PubMed ID: 1854656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic heart rate reduction: effect of a novel, specific bradycardic agent on the heart.
    Granetzny A; Schwanke U; Schmitz C; Arnold G; Schäfer D; Schulte HD; Gams E; Schipke JD
    Thorac Cardiovasc Surg; 1998 Apr; 46(2):63-9. PubMed ID: 9618805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol.
    Schulz R; Rose J; Skyschally A; Heusch G
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):216-28. PubMed ID: 7752647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional redistribution of myocardial perfusion by UL-FS 49, a selective bradycardic agent.
    O'Brien P; Drage D; Saeian K; Brooks HL; Warltier DC
    Am Heart J; 1992 Mar; 123(3):566-74. PubMed ID: 1539507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the haemodynamic effects of the selective bradycardic agent UL-FS 49, with those of propranolol during treadmill exercise in dogs.
    Krumpl G; Winkler M; Schneider W; Raberger G
    Br J Pharmacol; 1988 May; 94(1):55-64. PubMed ID: 3401644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of zatebradine on contractility, relaxation and coronary blood flow.
    Breall JA; Watanabe J; Grossman W
    J Am Coll Cardiol; 1993 Feb; 21(2):471-7. PubMed ID: 8426013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent".
    Kobinger W; Lillie C
    Eur J Pharmacol; 1984 Sep; 104(1-2):9-18. PubMed ID: 6499920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the bradycardic agent UL-FS 49 on exercise-induced regional contractile dysfunction in dogs.
    Raberger G; Krumpl G; Schneider W
    Int J Cardiol; 1987 Mar; 14(3):343-54. PubMed ID: 3557712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bradycardic agent, UL-FS 49, increases atrial force and decreases ventricular force in isolated, perfused heart preparations of dogs.
    Furukawa Y; Takayama S; Sawaki S; Inoue Y; Chiba S
    J Pharmacol Exp Ther; 1993 May; 265(2):801-6. PubMed ID: 8496825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of a potassium channel blocking drug, UK-68,798, and a specific bradycardic agent, UL-FS 49, on exercise-induced ischemia in the dog: significance of diastolic time on ischemic cardiac function.
    Gout B; Jean J; Bril A
    J Pharmacol Exp Ther; 1992 Sep; 262(3):987-94. PubMed ID: 1527735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of a new bradycardic substance on the isolated rabbit heart].
    Granetzny A; Schwanke U; Schmitz C; Schmitz-Spanke S; Arnold G; Schulte HD; Schipke JD
    Z Kardiol; 1996 Dec; 85(12):953-60. PubMed ID: 9082674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of arginine vasopressin on isolated guinea pig heart function during perfusion at constant flow and constant pressure.
    Graf BM; Fischer B; Martin E; Bosnjak ZJ; Stowe DF
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):1-7. PubMed ID: 9007663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sinus node inhibitor UL-FS 49 lacks significant inotropic effect.
    Chen ZY; Slinker BK
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):264-71. PubMed ID: 1376796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of two new bradycardic agents, AQ-AH 208 and UL-FS 49, on ischemic myocardial perfusion and function.
    Dämmgen JW; Lamping KA; Gross GJ
    J Cardiovasc Pharmacol; 1985; 7(1):71-9. PubMed ID: 2580154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of propofol and thiopental on coronary blood flow and myocardial performance in an isolated rabbit heart.
    Mouren S; Baron JF; Albo C; Szekely B; Arthaud M; Viars P
    Anesthesiology; 1994 Mar; 80(3):634-41. PubMed ID: 8141459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic cardiac and regional haemodynamic effects of the novel bradycardic agent, S16257, in conscious rats.
    Gardiner SM; Kemp PA; March JE; Bennett T
    Br J Pharmacol; 1995 Jun; 115(4):579-86. PubMed ID: 7582475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective bradycardic effects of zatebradine (UL-FS 49) do not adversely affect left ventricular function in conscious pigs with chronic coronary artery occlusion.
    van Woerkens LJ; van der Giessen WJ; Verdouw PD
    Cardiovasc Drugs Ther; 1992 Feb; 6(1):59-65. PubMed ID: 1576097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The direct effects of enflurane on coronary blood flow, myocardial oxygen consumption, and myocardial segmental shortening in in situ canine hearts.
    Gurevicius J; Holmes CB; Salem MR; Abdel-Halim A; Crystal GJ
    Anesth Analg; 1996 Jul; 83(1):68-74. PubMed ID: 8659768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific bradycardic agents, a new therapeutic modality for anesthesiology: hemodynamic effects of UL-FS 49 and propranolol in conscious and isoflurane-anesthetized dogs.
    Riley DC; Gross GJ; Kampine JP; Warltier DC
    Anesthesiology; 1987 Nov; 67(5):707-16. PubMed ID: 3674471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.